Manama:The National Health Regulatory Authority (NHRA) has improved its registration service for international pharmaceutical manufacturers, aligning with government efforts to enhance service quality and streamline procedures.
According to Bahrain News Agency, the enhanced service allows agents to register international pharmaceutical manufacturers through a new electronic system, facilitating the import and export of medicines from registered manufacturers. The processing time for the service has been reduced from 30 to 20 working days, the number of procedures has decreased from five to three, and the necessary documents have been cut from 11 to six.
Additional improvements include a 25% reduction in the service level agreement, limiting application steps to a maximum of four, achieving complete digitalisation, and enhancing the user experience. The number of required approvals has also been reduced by 25%, while service information has been standardised across all channels.
Dr. Ahmed Mohamed Al Ansari, Chief Executive Officer of the NHRA, stated that these enhancements aim to improve regulatory efficiency, simplify registration procedures, and facilitate transactions for agents. He highlighted that the transition to electronic services reflects the authority's commitment to developing integrated services that meet the needs of institutions and customers. Dr. Al Ansari also emphasised that the NHRA continues to review and develop its services, focusing on simplifying procedures, clarifying requirements, and improving operational efficiency to enhance service quality and customer experience.